DAFTAR PUSTAKA
1. Djoerban Z, Djauzi. HIV/AIDS di Indonesia. Dalam: Buku Ajar Ilmu Penyakit Dalam, Jilid III, Edisi V, Pusat Penerbit Departemen Ilmu Penyakit Dalam FKUI, Jakarta: 2009 November; 2861-8.
2. Nasronudin. Penatalaksanaan Klinis Infeksi HIV & AIDS. Dalam: HIV AIDS, Pendekatan Biologi Molekuler, Klinis dan Sosial. Barakbah J, Soewandojo E, Suharto, Hardi U, Astuti WD. Universitas Airlangga. Surabaya: 2007; 31-43.
3. Fauci AS and Lane HC. Human Immunodeficiency Virus disease: AIDS and related disorders. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL (eds). Harrison’s Principles of Internal Medicine Volume 1. 17th Edition. New York: Mc Graw Hill Companies. 2008; 1076-98.
4. U.S. Agency for International Development (2010). HIV/AIDS Health Profile.
5. United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the Global AIDS Epidemic 2012.
6. Kementerian Kesehatan Republik Indonesia. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan (Ditjen P2PL). Laporan Perkembangan HIV/AIDS. 2012.
8. Dinkes Provinsi Sumatera Utara. Kasus HIV/AIDS. Bidang Penanggulangan Penyakit Menular dan penyehatan Lingkungan (P2MPL). 2013.
9. Mehta S, Giovannuci E, Mugusi FM et al. Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia and Mortality. Plos One. 2010; 5:e8770.
10.Kementerian Kesehatan Republik Indonesia. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan (Ditjen P2PL). Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral pada Orang Dewasa dan Remaja. 2011.
11.World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. 2010.
12.Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266-8. 13.Holick MF. Sunlight and Vitamin D for Bone Health and Prevention of
Autoimmune Dissease, Cancers, and Cardiovascular Dissease. Am J Clin Nutr. 2004; 80(suppl):1678S– 88S.
14.Carolien JP, Bos M, Oyen WJG, et al. Vitamin D Deficiency Among HIV-1-Infected Individuals in The Netherlands: Effects of Antiretroviral Therapy. Aids Research and Human Retroviruses. 2008; 24: 1375-82. 15.Botella AC, Florence E, Lynen L, et al. Decrease of Vitamin D
Concentration in Patients with HIV Infection on a Non-nucleoside Reverse transcriptase Inhibitor-Containing regimen. 2010.
16.Melamed ML, Michos ED, Post W, et al. 25-hydroxyl Vitamin D Levels and Risk Mortaliy in The General Populations. Arch Intern Med. 2008; 168:1629–37.
17.Ellfolk M, Norlin M, Gyllensten, et al. Regulation of Human Vitamin D (3) 25-Hydroxylases in Dermal Fibroblasts and Protease Cancer LNCaP Cells. Mol Pharmacol. 2009; 75:1392-99.
India, with or without Antirretroviral Therapy. Endocrine Practice. 2010; 16: 547-53.
19.Cozzolino M, Vidal M, Arcidiacono MV, et al. HIV-Protease Inhibitors Impair Vitamin D Bioactivation to 1,25-Dihydroxyvitamin D. AIDS. 2003; 17: 513-20.
20.Chorol T, Das S, Choudhry S, Ramachandran VG, Ranga GS, Bhattacharya SN, Bhadoria DP. Absolute Lymphocyte Count: A useful Surrogate Marker to Initiate Antiretroviral Therapy in Resource Poor Settings. Asian Pacific Journal of Tropical Disease. 2012; 744-7.
21.Fauci AS. HIV and AIDS: 20 Years of Science. Nature Medicine. 2008; 9(7): 839-43.
22.Levy JA. HIV Pathogenesis: 25 Years of Progress and Persistent Challenges. AIDS. 2009; 23: 147-60.
23.Montagnier L. 25 Years After HIV Discovery: Prospects for Cure and Vaccine. Nobel Lecture, World Foundation for AIDS Research and Prevention, UNESCO. 2008.
24.Belasio FE, Raimondo M, Suligoi B, Butto S. HIV Virology and Pathogenetic Mechanism of Infection: A Brief Overview, Ann 1st Super Sanita. 2010; 46(1):5-14.
25.Liu PT, Stenger S, Tang DH, et al. Cutting Edge: Vitamin D Mediated Human Antimicrobial Activity Against Mycobacterium Tuberculosis is Dependent on The Induction of Cathelicidin. J Immunol. 2007;179:2060-63.
26.World Health Organization, Regional Office for South-East Asia. Management of HIV Infection and Antiretroviral Therapy in Adults and Adolescents. A Clinical Manual. 2007.
28.World Health Organization (b). WHO Case Definitions of HIV and Revised Clinical Staging and Immunological Clasification of HIV-Related Disease in Adult and Children. 2007.
29.World Health Organization (a). Laboratory Guidelines for Enumerating CD4 T Lymphocytes in the Context of HIV/AIDS. 2007.
30.Wormster GP. The Epidemiologi of HIV and AIDS in AIDS and Other Manifestation of HIV Infection. New York: Medical College Villaha. 2005.
31.Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral Therapy for HIV Infection in 1996. Recommendations of an
International Panel. International AIDS Society-USA. JAMA. 1996;276(2):46-54.
32.Max B, Sherer R. Management of The Adverse of Antiretroviral Therapy and Medication Adherence. Clinical Infection Disease. 2000;30 (Suppl 2): S96-116.
33.Ammassari A, Antinori A, Cozzi-Lepri A, Trotta MP, Nasti G, Ridolfo AL, et al.
Relationship Between HAARTAdherence and Adipose Tissue Alterations. J Acquir Immune Defic Syndr 2002;31 (Suppl 3):140-4. 34.Jagriti P. Pharmacokinetic Boosting of Zidovudine for HIV Treatment,
Int J of Pharmac and Clin Research. 2012;4(3):31-6.
35.Bouvier G. Protease Inhibitors Can Interfere With Vitamin D Metabolism. HIV Clinician. 2009;9-10.
36.Hewison M. Vitamin D, Immunity and Human Disease. Clinical Rev Bone Miner Metabolit. 2010;8:32-39.
1,25-Association With Immunological Hyperactivity and Only Minor Changes in Calcium Homeostasis. JCE&M. 1998;83:3832-38.
40.Direktorat Jenderal Pemberantasan Penyakit Menular dan Penyehatan Lingkungan, Departemen Kesehatan Republik Indonesia. Pedoman Nasional Perawatan, Dukungan dan Pengobatan Bagi ODHA. Jakarta. Dep Kes RI. 2003.
41.Spaulding A, Rutherford GW, Siegfried N. Tenofovir or Zidovudine in Three-Drug Combination Therapy with One Nucleoside Reverse Transcriptase Inhibitor and One Non-Nucleoside Reverse Transcriptase Inhibitor for Initial Treatment of HIV Infection in Antiretroviral-Naive Individuals. Wiley. Cochrane Collaboration. 2011;2:1-28.
42.Ramayo E, Moreno MPG, Macias J, et al. Relationship Between Osteopenia, Free Testosterone, and Vitamin D Metabolite Levels in HIV-Infected Patients With and Without Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 2005;2:915-21.
43.Liz H et al. Vitamin D Deficiency is Common Among HIV Positive People and Is Associated with NNRTI Use, Black Race and Sunning. 2009.
44.Viard JP et al. Vitamin D and Clinical Disease Progression in HIV Infection: Results from The EuroSIDA Study. AIDS. 2011.
45.Chakborty H, Newman JE, Woelk G, Foday H, Peres JI. Antiretroviral Therapy Initiation and CD4 Progression Over time Among HIV Infected Adults in Centra Africa. Int J of Med and Public Health. 2011; 1(4):3-11. 46.Gazzard B. What We Know So Far. AIDS. 1996;10(Suppl 1):S3-7. 47.Childs K, Kadis C, Baranch-Elliman W. Vitamin D and Calcium
Supplements Reverse The Secondary Hyperparathyroidsm That Commonly Occurs in HIV Patients on TDF-Containing HAART. HIV Med. 2009;10:p89.
Adults in The US General Population. Clinical Infectious Disseases. 2011;52:396-405.
49.Harkness L, Cromer B. Low Levels of 25-Hydroxy Vitamin D are Associated with Elevated Parathyroid Hormone in Healthy Adolescent Females. Osteoporos Int. 2005;16:109-13.
50.Herzmann C, Arasteh K. Efavirenz Induced Osteomalacia. AIDS. 2009;23:273–78.
51.Vescini F. Vitamin D Deficiency in HIV-Positive Patients. HAART and Correlated Pathologies. 2010;7:7-11.
